MedMiraJun 6, 20224 minMedMira Receives Patent for its Unique Quantitative Diagnostic SystemHalifax, Nova Scotia, June 6, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450)...
MedMiraMay 27, 20222 minUpdate on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European MarketHalifax, Nova Scotia, 27 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe...
MedMiraMay 20, 20222 minVYRA™ Product Line UpdateHalifax, Nova Scotia, 20 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the Company’s regulatory work for...
MedMiraMay 18, 20221 minTest yourself in a smart wayA fact sheet for the importance of testing for both TP/nTP. Multiplo Compete Syphilis (TP/nTP) Antibody Test - testing was never so easy...
MedMiraMay 12, 20222 minMedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody TestHalifax, Nova Scotia, 12 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its...
MedMiraApr 29, 20221 minPractical TestingNow available in a small box (5 Tests) ideal for travel or home use.